Therapeutic trials of multiple sclerosis and intrathecal IgG production
- PMID: 3013800
- DOI: 10.1007/BF02230883
Therapeutic trials of multiple sclerosis and intrathecal IgG production
Abstract
In our clinical trial we have compared the effect of high doses of prednisone, ACTH alone or ACTH and cyclophosphamide on plasma and CSF albumin and IgG levels. We have found that the treatment with high doses of prednisone is more effective in the suppression of CNS IgG synthesis than ACTH, or cyclophosphamide. However the significance of this immunological phenomenon in the pathogenesis of MS is a very complex problem, since we have not observed any correlation between the depression of the intrathecal IgG synthesis and clinical results of MS treatment.
Similar articles
-
Multiple sclerosis de novo CNS IgG synthesis. Effect of CNS irradiation.Arch Neurol. 1980 Oct;37(10):620-4. doi: 10.1001/archneur.1980.00500590044005. Arch Neurol. 1980. PMID: 6252876
-
[Effect of ACTH therapy on IgG synthesis in cerebrospinal fluid spaces in patients with disseminated sclerosis].Neurol Neurochir Pol. 1986 Sep-Oct;20(5):437-43. Neurol Neurochir Pol. 1986. PMID: 3035406 Polish.
-
Schemes to eradicate the multiple sclerosis central nervous system immune reaction.Neurology. 1976 Jun;26(6 PT 2):59-61. doi: 10.1212/wnl.26.6_part_2.59. Neurology. 1976. PMID: 179031 No abstract available.
-
A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis.Neurology. 1978 Sep;28(9 Pt 2):132-9. doi: 10.1212/wnl.28.9_part_2.132. Neurology. 1978. PMID: 213744 Review. No abstract available.
-
On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.J Neurol Sci. 1970 Mar;10(3):279-304. doi: 10.1016/0022-510x(70)90156-5. J Neurol Sci. 1970. PMID: 4909729 Review. No abstract available.
Cited by
-
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.Mult Scler Int. 2015;2015:296184. doi: 10.1155/2015/296184. Epub 2015 Jan 8. Mult Scler Int. 2015. PMID: 25653878 Free PMC article. Review.
-
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.Mult Scler. 2012 Feb;18(2):202-9. doi: 10.1177/1352458511419701. Epub 2011 Aug 24. Mult Scler. 2012. PMID: 21865410 Free PMC article.
References
-
- Immunochemistry. 1965 Sep;2(3):235-54 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical